Samuel Bates Martin

Insider Reports History

Location
Hampton, NJ
Signature
/s/ Anthony S. Marucci, attorney-in-fact for Samuel Bates Martin
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Samuel Bates Martin:

Company Role Class Num Shares Value Price $ Report Date Ownership
Celldex Therapeutics, Inc. SVP AND CFO Common Stock 32,942 $341,937 $10.38 02 Jan 2026 Direct
Celldex Therapeutics, Inc. SVP AND CFO Incentive Stock Option (Right to Buy) 58,815 02 Jan 2026 Direct

Insider Reports Filed by Samuel Bates Martin

Symbol Company Period Transactions Value $ Form Type Role Filing Time
CLDX Celldex Therapeutics, Inc. 02 Jan 2026 2 +$50,000 4 SVP AND CFO 06 Jan 2026, 16:23
CLDX Celldex Therapeutics, Inc. 05 Jun 2025 1 $0 4 SVP AND CFO 09 Jun 2025, 16:17
CLDX Celldex Therapeutics, Inc. 14 Jun 2024 5 -$403,325 4 SVP AND CFO 18 Jun 2024, 16:05
CLDX Celldex Therapeutics, Inc. 13 Jun 2024 1 $0 4 SVP AND CFO 17 Jun 2024, 16:13
CLDX Celldex Therapeutics, Inc. 30 May 2024 3 -$932,274 4 SVP AND CFO 03 Jun 2024, 16:05
CLDX Celldex Therapeutics, Inc. 02 Jan 2024 2 +$29,885 4 SVP AND CFO 04 Jan 2024, 16:05
CLDX Celldex Therapeutics, Inc. 15 Jun 2023 1 $0 4 SVP AND CFO 20 Jun 2023, 16:17
CLDX Celldex Therapeutics, Inc. 11 Aug 2022 10 -$635,414 4 SVP AND CFO 15 Aug 2022, 16:16
CLDX Celldex Therapeutics, Inc. 16 Jun 2022 1 $0 4 SVP AND CFO 17 Jun 2022, 16:13
CLDX Celldex Therapeutics, Inc. 23 Dec 2021 5 -$359,271 4 SVP and CFO 28 Dec 2021, 15:02
CLDX Celldex Therapeutics, Inc. 15 Nov 2021 6 -$374,155 4 SVP and CFO 17 Nov 2021, 15:02
CLDX Celldex Therapeutics, Inc. 10 Aug 2021 6 -$207 4 SVP and CFO 12 Aug 2021, 10:00
CLDX Celldex Therapeutics, Inc. 17 Jun 2021 1 $0 4 SVP and CFO 21 Jun 2021, 16:26